Kara Yasin, Kocataş Ali, Köneş Osman, Somuncu Erkan, Gök İlhan, Yilmaz Gulseren, Topal Ümmihan, Kalaycı Mustafa Uygar
Department of General Surgery, University of Health Sciences, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul-Türkiye.
Department of General Surgery, Medicana Zincirlikuyu Hospital, Istanbul-Türkiye.
Ulus Travma Acil Cerrahi Derg. 2025 Sep;31(9):867-875. doi: 10.14744/tjtes.2025.20283.
This study aimed to determine the reliability and efficacy of endoscopic retrograde cholangiopancreatography (ERCP) in elderly patients compared with younger patients.
In this retrospective study, ERCP procedures performed in our endoscopy unit between December 2020 and October 2024 were reviewed. Elderly patients aged ≥80 years (AA group) and younger patients aged <65 years (control group) were included. Their demographics, comorbidities, American Society of Anesthesiologists (ASA) scores, ERCP indications, procedural success, and complications were compared.
There were significant differences in ASA scores, comorbidities, and the use of anticoagulant or antiplatelet drugs between the groups (p<0.05, p<0.01, and p<0.05, respectively). Juxtapapillary diverticula were more common in the AA group than in the control group (21% vs. 5.1%, p<0.01). Regarding indications, choledocholithiasis and obstructive jaundice were the most common in both groups (p=0.456 and p=0.064, respectively). The rate of cannulation success was not significantly different between the groups (p=0.956). Sphincterotomy and stone extraction with balloon or basket were the most frequent interventions in both groups (p=0.22 and p=0.563, respectively). Postprocedural pancreatitis was significantly more common in the control group than in the AA group (p=0.041). No significant differences were found in other complications, including bleeding, perforation, infection, basket impaction, and cardiopulmonary events between the groups (p=0.436, p=0.354, p=0.958, p=0.254, and p=0.289, respectively).
Therapeutic ERCP procedures can be performed safely and efficiently in elderly patients, as their outcomes are comparable to those observed in younger patients.
本研究旨在确定与年轻患者相比,内镜逆行胰胆管造影术(ERCP)在老年患者中的可靠性和有效性。
在这项回顾性研究中,对2020年12月至2024年10月在我们内镜科进行的ERCP手术进行了回顾。纳入年龄≥80岁的老年患者(AA组)和年龄<65岁的年轻患者(对照组)。比较了他们的人口统计学、合并症、美国麻醉医师协会(ASA)评分、ERCP适应症、手术成功率和并发症。
两组之间的ASA评分、合并症以及抗凝或抗血小板药物的使用存在显著差异(分别为p<0.05、p<0.01和p<0.05)。AA组中乳头旁憩室比对照组更常见(21%对5.1%,p<0.01)。关于适应症,胆总管结石和梗阻性黄疸在两组中最为常见(分别为p=0.456和p=0.064)。两组之间插管成功率无显著差异(p=0.956)。括约肌切开术以及用球囊或网篮取石是两组中最常见的干预措施(分别为p=0.22和p=0.563)。术后胰腺炎在对照组中比AA组明显更常见(p=0.041)。两组之间在其他并发症方面未发现显著差异,包括出血、穿孔、感染、网篮嵌顿和心肺事件(分别为p=0.436、p=0.354、p=0.958、p=0.254和p=0.289)。
治疗性ERCP手术在老年患者中可以安全有效地进行,因为其结果与年轻患者相当。